Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31365801

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Aug 1
First author
Shanafelt TD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):592. doi: 10.1038/s41571-019-0265-6.
    note
    Source null
    related pmid
    31417194
    relationship
    Comment in

Authors and identifiers

  1. name
    Shanafelt TD
    type
    Author
  2. name
    Wang XV
    type
    Author
  3. name
    Kay NE
    type
    Author
  4. name
    Hanson CA
    type
    Author
  5. name
    O'Brien S
    type
    Author
  6. name
    Barrientos J
    type
    Author
  7. name
    Jelinek DF
    type
    Author
  8. name
    Braggio E
    type
    Author
  9. name
    Leis JF
    type
    Author
  10. name
    Zhang CC
    type
    Author
  11. name
    Coutre SE
    type
    Author
  12. name
    Barr PM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shanafelt TD
    type
    Author
  2. name
    Wang XV
    type
    Author
  3. name
    Kay NE
    type
    Author
  4. name
    Hanson CA
    type
    Author
  5. name
    O'Brien S
    type
    Author
  6. name
    Barrientos J
    type
    Author
  7. name
    Jelinek DF
    type
    Author
  8. name
    Braggio E
    type
    Author
  9. name
    Leis JF
    type
    Author
  10. name
    Zhang CC
    type
    Author
  11. name
    Coutre SE
    type
    Author
  12. name
    Barr PM
    type
    Author
bibliography ids
  1. nci-bib-dcad173dccca2a71b09b53ea
book metadata
content sha256
eff1001a148e057b834fbfc33f94ecfb2c667fef0676c81bac76a369baa3d867
document type
citation
dois
  1. 10.1056/NEJMoa1817073
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31365801
immutable id
pubmed:31365801@eff1001a148e057b834fbfc33f94ecfb2c667fef0676c81bac76a369baa3d867
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
5
name
The New England journal of medicine
nlm unique id
0255562
pages
432-443
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):592. doi: 10.1038/s41571-019-0265-6.
    note
    Source null
    related pmid
    31417194
    relationship
    Comment in
outcomes validated
false
pmid
31365801
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
c5b12de11a47c26fdbe62b8e2ab464fb437f07a36c678f994560fb4341ac6bf0
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Aug 1
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31365801/
title
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

Preserved source evidence · Not medical advice